Screening patients with scleroderma for pulmonary arterial hypertension and implications for other at-risk populations

Pulmonary arterial hypertension (PAH) is a progressive vasculopathy that is advanced by the time symptoms develop. As symptoms are nonspecific and the condition uncommon, continued progression toward end-stage disease occurs for an average of 2 years between symptom onset and diagnosis. There is nee...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwaiger, Johannes P., Khanna, Dinesh, Gerry Coghlan, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639190/
https://www.ncbi.nlm.nih.gov/pubmed/24293467
http://dx.doi.org/10.1183/09059180.00006013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639190/
https://www.ncbi.nlm.nih.gov/pubmed/24293467
http://dx.doi.org/10.1183/09059180.00006013

Ejemplares similares